PM
Prime Medicine, Inc. Common Stock
🇺🇸XNAS.PRMEUnited StatesHealthcare
$2.96USDdown -0.19 (-6.03%)ClosedDelayed11:25 PM
Price$2.96-0.19 (-6.03%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US74168J1016
- CUSIP
- 74168J101
Company
- Employees
- 146
- Headquarters
- Cambridge, United States
- Website
- https://primemedicine.com
- CEO
- Dr. Allan Reine M.D.
Market
- Shares outstanding
- 181.4M
- Market cap
- $536.88M
Highlights
- Market cap
- $567.71M
- EPS LTM
- -$1.04calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -2.86calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $4.07M-17.9%down year on year
- Net income
- -$187.89M+5.71%up year on year
- Gross margin
- -1,071.67%-2,730.96%down year on year
- Free cash flow
- -$156.85M-46.59%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.